Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
Quantimetrix Corp. — Predicate Candidate Screening
38 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
67 daysmedian FDA review time
191 days90th percentile
38clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K142262 | AUTION CHECK PLUS | Quantimetrix Corp. | 2015-04-10 | 239 | 0 |
| K113177 | COMPLETE D 25-OH VITAMIN D CONTROL | Quantimetrix Corp. | 2012-05-10 | 195 | 0 |
| K103744 | DROPPER A1C DIABETES CONTROL | Quantimetrix Corp. | 2011-05-12 | 140 | 0 |
| K062942 | QUANTIMETRIX NICOSURE COTININE URINE CONTROL | Quantimetrix Corp. | 2006-10-30 | 32 | 0 |
| K062751 | MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER | Quantimetrix Corp. | 2006-10-03 | 19 | 0 |
| K060417 | MODIFICATION TO QUANTIMETRIX URINE DRUGS OF ABUSE CONTROL | Quantimetrix Corp. | 2006-03-21 | 32 | 0 |
| K032791 | GLYCOHEMOSURE HBA1C CONTROL | Quantimetrix Corp. | 2003-10-30 | 52 | 0 |
| K030826 | PRECISET DAT AMPHETAMINE | Quantimetrix Corp. | 2003-04-03 | 20 | 0 |
| K021393 | PRECISET DAT PLUS | Quantimetrix Corp. | 2002-06-13 | 42 | 0 |
| K013662 | MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS | Quantimetrix Corp. | 2002-03-08 | 122 | 0 |
| K010337 | LIPOPRINT SYSTEM, LDL SUBFRACTIONS | Quantimetrix Corp. | 2001-07-25 | 170 | 0 |
| K010598 | SYNOVIALSCOPICS, SYNOVIAL FLUID CONTROL | Quantimetrix Corp. | 2001-03-23 | 23 | 1 |
| K993723 | CARDIASURE CARDIAC MARKERS CONTROL | Quantimetrix Corp. | 1999-11-23 | 20 | 0 |
| K973894 | IMMUSURE | Quantimetrix Corp. | 1997-10-29 | 15 | 0 |
| K970862 | SPINALSCOPICS | Quantimetrix Corp. | 1997-04-08 | 32 | 1 |
| K943394 | PROSTAT CONTROL | Quantimetrix Corp. | 1995-05-23 | 313 | 0 |
| K943925 | SWEAT CONTROLS FOR CYSTIC FIBROSIS TESTING | Quantimetrix Corp. | 1994-10-04 | 53 | 0 |
| K941130 | ASSURE URINE HCG CONTROL | Quantimetrix Corp. | 1994-06-03 | 86 | 0 |
| K932623 | QUANTIMETRIX BLOOD GLUCOSE CONTROLS | Quantimetrix Corp. | 1993-12-09 | 191 | 0 |
| K931523 | QUANTIMETRIX C-CLEAR(TM) | Quantimetrix Corp. | 1993-06-25 | 91 | 0 |
| K925256 | QUANTIMETRIX URINALYSIS MICROSCOPICS CONTROL | Quantimetrix Corp. | 1993-03-01 | 133 | 1 |
| K913346 | QUANTIMETRIX AMMONIA CONTROLS | Quantimetrix Corp. | 1991-09-25 | 61 | 0 |
| K880701 | QUANTIMETRIX SERUM ENZYME CONTROL | Quantimetrix Corp. | 1988-03-24 | 31 | 0 |
| K863388 | QUANTIMETRIX DRUG FREE SERUM CONTROL | Quantimetrix Corp. | 1986-09-29 | 26 | 0 |
| K861420 | QUANTIMETRIX DRUG FREE HUMAN URINE CONTROL | Quantimetrix Corp. | 1986-09-16 | 154 | 0 |
| K860942 | QUANTIMETRIX HUMAN BILIRUBIN CONTROL I & II LIQUID | Quantimetrix Corp. | 1986-05-23 | 72 | 0 |
| K853932 | QUANTTEST TOTAL PROTEIN ASSAY | Quantimetrix Corp. | 1985-12-19 | 86 | 0 |
| K853930 | QUANTIMETRIX BIURET SERUM TOTAL PROTEIN ASSAY KIT | Quantimetrix Corp. | 1985-12-10 | 77 | 0 |
| K853933 | QUANTIMETRIX HUMAN SERUM THERAPEUTIC DRUG CONTROL | Quantimetrix Corp. | 1985-10-04 | 10 | 0 |
| K853931 | QUANTIMETRIX HUMAN SERUM CHEMISTRY CONTROL | Quantimetrix Corp. | 1985-10-04 | 10 | 0 |
| K843818 | HUMAN SERUM ANTICONVULSANT DRUG CONTROL | Quantimetrix Corp. | 1984-10-30 | 32 | 0 |
| K843679 | HUMAN SERUM CARDIOACTIVE DRUG CONTROL | Quantimetrix Corp. | 1984-10-05 | 17 | 0 |
| K834505 | HUMAN SERUM ELECTROLYTE CONTROL-LIQUID | Quantimetrix Corp. | 1984-04-13 | 114 | 0 |
| K832045 | ACETAMINOPHER ASSAY KIT | Quantimetrix Corp. | 1983-10-04 | 102 | 0 |
| K831526 | URINE TOTAL PROTEIN CONTROL | Quantimetrix Corp. | 1983-08-12 | 92 | 0 |
| K831527 | SPINAL FLUID TOTAL PROTEIN CONTROL | Quantimetrix Corp. | 1983-07-18 | 67 | 0 |
| K831336 | SALICYLATE ASSAY KIT | Quantimetrix Corp. | 1983-07-07 | 73 | 0 |
| K830934 | QUANTIMETRIX BROMERESOL PURPLE ALBUMIN | Quantimetrix Corp. | 1983-04-18 | 26 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda